Skip to main content
TipRanks
Go Ultimate75% OFF

Silexion Therapeutics (SLXN) Balance Sheet

247 Followers

Silexion Therapeutics Balance Sheet

Silexion Therapeutics's total assets for Q3 2026 were $6.83M, an increase of 60.79% from the previous quarter. SLXN total liabilities were $3.86M for the fiscal quarter, a 8.16% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 7.21M$ 2.86M$ 5.26M$ 9.33M$ 115.41M
$ 4.61M$ 6.85M$ 17.31M$ 16.41M$ 508.92K
$ 2.60M$ -3.99M$ -12.06M$ -7.08M$ 114.91M

Currency in USD

Silexion Therapeutics Liabilities to Assets

050M100M150M0 %120 %240 %360 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets